Research Scientist (Assay Development)

Job Location
Cambridge, UK
CB21 5XE
United Kingdom
Industry leading package

Company equity, annual bonus scheme, 10% pension contribution, private medical care, share purchase plan and more!

Job Description

Illumina Reproductive & Genetic Health (RGH):

Make a difference! Illumina RGH uses the power of genomics to understand and improve the reproductive success of humans.  Join a team of award winning scientists, software developers and informaticians (Queens Award for Enterprise) that work at the forefront of personalized medicine and diagnostics.  This is your chance to work with a company changing the way we think about human reproductive health and providing tools that may one day make inherited disease a thing of the past.


Illumina RGH’s site in Fulbourn, Cambridge serves as a R&D, marketing, software development and production facility housing over 60 people in a high tech facility.  With laboratories and production facilities on site, this is a great place to work and really feel at the heart of the biotechnology revolution.



The Team:

Illumina’s reproductive and genomics solutions use next-generation sequencing (NGS) and advanced microarray technologies to produce fast, accurate genomic information in clinical research and diagnostics. Combining industry-leading technologies with innovative reproductive and genetic health applications, Illumina provides the highest detection capability for genetic abnormalities during all stages of reproductive health and beyond.  Across the reproductive continuum, Illumina technologies deliver valuable tools for researchers and healthcare professionals.  The Assay Development team work in conjunction with Software, Informatics and Product Marketing to deliver robust wet biological assays that support this goal.


The Role:

The role-holder will help create new products for the reproductive and genetic health market.  This is a hands-on role requiring an energetic molecular biologist and product developer. The role holder will work closely with senior scientists, designing and conducting experiments that contribute to the development of high quality clinical products against tight deadlines. They will be technically skilled, organised and collaborative, and will excel at problem solving.


This role would suit an early-career post-doctoral scientist who is looking for either their first move to industry or perhaps a new challenge within industrial science, and would welcome the opportunity to leverage their skills in this exciting and fast paced field.


Tasks and Responsibilities:


  • Experimental design (based on project outlines provided by senior scientists).
  • Independent execution of experiments in the laboratory.
  • Data analysis.
  • Presentation of results and conclusions to senior staff.
  • Methodical protocol optimization and trouble-shooting of issues.
  • Documentation of experimental plans and results within an ISO13485 certified Quality Management System.
  • Effective collaboration with colleagues across different functional teams, sites and countries.

The Candidate:


Required Educational Background:

  • Ph.D. in biology, molecular biology, genomics or related field.


                Preferred Experiential Background:

  • Proven experience in molecular biology and analytical sciences.
  • Evidence of creativity, initiative and collaborative ability.
  • Exceptional bench and analytical skills.
  • Demonstrable ability to communicate verbally and in scientific writing.
  • Experience of developing medical devices or IVDs would be advantageous.
About Our Organization

All About Us


Headquartered in San Diego, California, Illumina (NASDAQ: ILMN), is a leading developer, manufacturer, and marketer of next generation life science tools and integrated systems for large-scale analysis of genetic variation and biological function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With the innovative advances in our sequencing technologies, we are rapidly impacting the clinical market in areas such as reproductive health and oncology. The expanding Illumina oncology portfolio of next- generation sequencing NGS and microarray technologies is revolutionizing cancer genomics research. Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.


lllumina has experienced phenomenal growth from $10 million in revenues in 2002 to over $1.9 billion in 2014. Forbes named Illumina #1 on the 2009 list of 25 Fastest-Growing Technology Companies in the United States, the second time over a three year period that Forbes ranked Illumina #1 on its list of rapidly growing technology companies. Illumina was also named #1 smartest company in the world as part of MIT’s 2014 Technology Review.  As of December 2014, the company had a $26 billion market capitalization.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.

National Institute of Environmental Health Sciences researchers have visualized the career paths of former postdocs.

A new survey from the Pew Research Center finds that half of women working in STEM have experienced gender discrimination at work.